Document is current

Any future updates will be listed below

Comment on ‘An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers’ by Fukui et al.

Crossref DOI link: https://doi.org/10.1007/s12282-023-01527-5

Published Online: 2023-11-20

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark